PLSH Stock Analysis
PL
Uncovered
Panacea Life Sciences Holdings Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Panacea Life Sciences Holdings, Inc. engages in the development and production of medically relevant, legal, hemp-derived cannabinoid products for consumers and pets. The company is headquartered in Greenwood Village, Colorado and currently employs 29 full-time employees. The company went IPO on 2015-11-24. The firm operates through its subsidiary, Panacea Life Sciences, Inc. (PLS). The firm produces natural pharmaceutical alternatives for consumers and pets. The company manufactures and sells softgels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals. The firm offers its product across various brands, including PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Life and PANA Pure. The company sells over 60 different product stock keeping units (SKUs) of cannabidiol (CBD) and Cannabigerol (CBG) products. In addition, it offers white label licensing to retail businesses and contract manufacturing services to smaller CBD companies.